Shares of Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) traded up 7.4% on Wednesday. The company traded as high as $6.44 and last traded at $6.44. Approximately 1,000 shares were traded during trading, a decline of 84% from the average daily volume of 6,218 shares. The stock had previously closed at $5.9966.
Analyst Upgrades and Downgrades
Separately, Zacks Research raised Oxford BioMedica to a “hold” rating in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock has an average rating of “Hold”.
Check Out Our Latest Analysis on OXBDF
Oxford BioMedica Stock Performance
The stock’s 50-day moving average price is $7.12 and its 200-day moving average price is $7.74.
Oxford BioMedica Company Profile
Oxford BioMedica plc is a United Kingdom-based contract development and manufacturing organization (CDMO) focused on cell and gene therapies. The company helps biotechnology and pharmaceutical customers develop, test, and manufacture advanced therapies, with expertise in viral-vector technologies used to deliver genetic material into cells.
Its services include process and analytical development, clinical and commercial manufacturing, quality testing, regulatory support, and related research services.
Further Reading
- Five stocks we like better than Oxford BioMedica
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
